CLSA Wire

On Tuesday, August 20th, CLSA welcomed a host of lawmakers, legislative staffers, and other key stakeholders to a first of its kind medical device showcase reception in Sacramento.

On behalf of our membership and California’s statewide life sciences community – a sector which employs over 311,000 Californians – California Life Sciences Association (CLSA) welcomes Senator Susan Rubio (D-Baldwin Park). We look forward to working with Senator Rubio and her team to advance policies that improve patient health and bring positive change for California patients and their families.

When Congress returns from the District Work period (“August recess”) in September, there will be only 10 legislative weeks remaining for Congress to take action to prevent the Medical Device Excise Tax from going back into effect on January 1, 2020. CLSA has worked closely with our membership, our national trade association partners, allied stakeholders and congressional champions to introduce the Protect Medical Innovation Act of 2019 (H.R. 2207), which would permanently repeal this innovation stifling tax. 

On July 9th, the California Senate Judiciary Committee, which is chaired by Senator Hannah Beth Jackson (D-Santa Barbara), heard eight different bills amending the California Consumer Privacy Act of 2018 (CCPA), six of which passed.

On July 16, Senator Kamala Harris (D-CA) released a plan proposing international price controls as part of her solution to lower drug costs. This latest action demonstrates growing bipartisan interest in using the dangerous concept of price controls as a mechanism for lowering list prices for pharmaceuticals in the U.S.